CAR T cells show superiority over standard therapies for RRMM
- PMID: 36849555
- DOI: 10.1038/s41571-023-00749-y
CAR T cells show superiority over standard therapies for RRMM
Comment on
-
Ide-cel or Standard Regimens in Relapsed and Refractory Multiple Myeloma.N Engl J Med. 2023 Mar 16;388(11):1002-1014. doi: 10.1056/NEJMoa2213614. Epub 2023 Feb 10. N Engl J Med. 2023. PMID: 36762851 Clinical Trial.
References
Original article
-
- Rodriguez-Otero, P. et al. Ide-cel or standard regimens in relapsed and refractory multiple myeloma. N. Engl. J. Med. https://doi.org/10.1056/NEJMoa2213614 (2023) - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical